Cerevel Therapeutics Ownership | Who Owns Cerevel Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Cerevel Therapeutics Ownership Summary

Cerevel Therapeutics is owned by 84.67% institutional investors, 15.33% insiders. Bain capital investors is the largest institutional shareholder, holding 36.17% of CERE shares. Fidelity Canadian Large Cap Sr B is the top mutual fund, with 0.88% of its assets in Cerevel Therapeutics shares.

CERE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cerevel Therapeutics	84.67%	15.33%	-
Sector	Healthcare Stocks	46.98%	7.90%	45.12%
Industry	Biotech Stocks	44.85%	7.67%	47.48%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bain capital investors	65.68M	36.17%	$2.69B
Perceptive advisors	10.79M	5.94%	$441.40M
Avoro capital advisors	7.54M	4.15%	$308.29M
Vanguard group	7.15M	3.94%	$292.54M
Blackrock	3.56M	1.96%	$145.61M
Fil	3.25M	1.79%	$132.97M
State street	3.11M	1.71%	$127.16M
Alpine associates management	2.35M	1.30%	$96.24M
Norges bank	2.34M	1.29%	$95.51M
Paradigm biocapital advisors lp	2.33M	1.28%	$95.29M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bain capital investors	65.68M	57.02%	$2.69B
Twin securities	416.66K	13.40%	$17.04M
Sand grove capital management llp	919.02K	10.99%	$37.58M
Perceptive advisors	10.79M	10.48%	$441.40M
Alpine associates management	2.35M	4.60%	$96.24M
Avoro capital advisors	7.54M	4.11%	$308.29M
Melqart asset management (uk)	1.10M	3.72%	$44.95M
Paradigm biocapital advisors lp	2.33M	3.65%	$95.29M
Water island capital	766.93K	3.33%	$31.36M
Gardner lewis asset management l p	192.15K	2.15%	$7.86M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	2.34M	0.01%	2.34M
Qube research	1.23M	0.08%	1.06M
Sand grove capital management llp	919.02K	10.99%	919.02K
Ameriprise financial	1.35M	0.01%	784.91K
Marshall wace, llp	1.87M	0.10%	647.07K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	3.56M	0.00%	-1.89M
Fmr	4.88K	-	-1.79M
Baker bros. advisors lp	683.59K	0.36%	-916.41K
Man group	337.27K	0.03%	-640.27K
Citigroup	1.28M	0.03%	-611.06K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	2.34M	0.01%	2.34M	$95.51M
Sand grove capital management llp	919.02K	10.99%	919.02K	$37.58M
Grantham, mayo, van otterloo	508.84K	0.07%	508.84K	$20.81M
Pentwater capital management lp	400.00K	0.21%	400.00K	$16.36M
Trium capital llp	317.73K	1.64%	317.73K	$12.99M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-13.00
First manhattan co. llc.	-100.00
Quest partners	-423.00
Css llc/il	-2.00K
Belvedere trading	-2.40K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	265	16.23%	153,774,816	0.20%	84	0.94%	125	2.46%	72	35.85%
Mar 31, 2024	228	-0.44%	153,464,068	-0.43%	94	0.99%	122	-20.78%	53	51.43%
Dec 31, 2023	229	77.52%	154,125,073	9.92%	97	1.23%	154	90.12%	35	40.00%
Sep 30, 2023	129	-5.84%	140,209,416	1.08%	89	1.14%	81	15.71%	25	-44.44%
Jun 30, 2023	137	1.48%	138,705,432	2.45%	88	1.19%	70	22.81%	45	12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Canadian Large Cap Sr B	1.61M	0.88%	10.00K
Fidelity Canadian Large Cp Mlt Ast Bs O	1.10M	0.60%	320.00K
Fidelity Small Cap Index	752.79K	0.41%	39.79K
The Merger Fund A	626.71K	0.34%	33.75K
Fidelity Extended Market Index	520.58K	0.29%	15.63K
Eventide Healthcare & Life Sciences I	490.00K	0.27%	-
Arbitrage R	473.47K	0.26%	-
GAMCO Intl SICAV Merger Arbtrg I (USD)	363.89K	0.20%	363.89K
AB Merger Arbitrage S1 USD	319.85K	0.18%	-
Fidelity Concntr Val Priv Pool Sr F	297.00K	0.16%	-2.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 01, 2024	COLES N ANTHONY	-	Sell	$1.03M
Jun 03, 2024	COLES N ANTHONY	-	Sell	$2.03M
May 10, 2024	COLES N ANTHONY	-	Sell	$2.11M
Apr 01, 2024	COLES N ANTHONY	-	Sell	$2.12M
Mar 04, 2024	COLES N ANTHONY	-	Sell	$2.05M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	1
2024 Q2	-	3
2024 Q1	-	5
2023 Q4	4	18
2023 Q3	2	2

CERE Ownership FAQ

Who Owns Cerevel Therapeutics?

Cerevel Therapeutics shareholders are primarily institutional investors at 84.67%, followed by 15.33% insiders and -0.00% retail investors. The average institutional ownership in Cerevel Therapeutics's industry, Biotech Stocks , is 44.85%, which Cerevel Therapeutics exceeds.

Who owns the most shares of Cerevel Therapeutics?

Cerevel Therapeutics’s largest shareholders are Bain capital investors (65.68M shares, 36.17%), Perceptive advisors (10.79M shares, 5.94%), and Avoro capital advisors (7.54M shares, 4.15%). Together, they hold 46.26% of Cerevel Therapeutics’s total shares outstanding.

Does Blackrock own Cerevel Therapeutics?

Yes, BlackRock owns 1.96% of Cerevel Therapeutics, totaling 3.56M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 145.61M$. In the last quarter, BlackRock decreased its holdings by -1.888M shares, a -34.65% change.

Who is Cerevel Therapeutics’s biggest shareholder by percentage of total assets invested?

Bain capital investors is Cerevel Therapeutics’s biggest shareholder by percentage of total assets invested, with 57.02% of its assets in 65.68M Cerevel Therapeutics shares, valued at 2.69B$.

Who is the top mutual fund holder of Cerevel Therapeutics shares?

Fidelity Canadian Large Cap Sr B is the top mutual fund holder of Cerevel Therapeutics shares, with 0.88% of its total shares outstanding invested in 1.61M Cerevel Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools